Monitor for the appointment of a successor auditor and any subsequent NT 10-K filing if the FY 2026 audit is delayed. The lack of an auditor raises going-concern and delisting risk for this OTC-traded micro-cap.
Price Chart
Executive Summary
CTT Pharmaceutical Holdings' independent auditor, Holt & Patterson, LLC, resigned effective October 2, 2026, citing a decision to stop handling SEC reporting companies. The company has no current auditor and must find a replacement to complete its FY 2026 audit, creating uncertainty around timely financial reporting.
Key Facts
- Auditor Holt & Patterson, LLC resigned effective October 2, 2026, and will not complete the audit for the year ended December 31, 2026.
- The company stated there were no disagreements on accounting practices; the auditor is simply not handling SEC reporting companies moving forward.
- Outstanding professional fees of $4,825.00 from the FY 2025 audit remain due and payable to the former auditor.
- CTT Pharma will begin searching for a new auditor and plans to reach out to one it has worked with before.
- The resignation was disclosed via an 8-K filed October 7, 2026, with Item 4.01 (Change in Accountant) and Item 9.01 (Financial Statements and Exhibits).
Financial Impact
No financial figures reported in the filing beyond $4,825 in outstanding audit fees.
Risk Factors
- Delayed or non-filed FY 2026 annual report (10-K) if a new auditor is not engaged promptly.
- Potential OTC Markets delinquency or trading suspension if financial reports are not current.
- Going-concern risk amplified by inability to retain an SEC-reporting auditor for a micro-cap pharmaceutical company.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001477932-26-006099 |
| Document: ctth_ex161.htm | 0001477932-26-006099 |
| Document: 0001477932-26-006099-index-headers.html | 0001477932-26-006099 |
| Document: 0001477932-26-006099-index.html | 0001477932-26-006099 |
| Document: 0001477932-26-006099.txt | 0001477932-26-006099 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | 8-K | $0.0566 | awaiting T+60 | — | $0.0570 (+0.71%) |
Oct 7, 2026 19d ago | 8-K | $0.0566 | awaiting T+60 | — | $0.0570 (−0.71%) |
Aug 12, 2026 10w ago | 8-K | $0.0660 | awaiting T+60 | — | $0.0570 (−13.64%) |
Jul 24, 2026 13w ago | S-1/A | $0.0660 $0.0589 | ▲ +10.76% | ▲ +14.31% | $0.0570 (+13.64%) |
Jun 29, 2026 17w ago | S-1/A | $0.0750 $0.0485 | ▲ +35.33% | ▲ +38.38% | $0.0570 (+24.00%) |
Jun 16, 2026 18w ago | S-1/A | $0.0800 $0.0518 | ▲ +35.25% | ▲ +38.66% | $0.0570 (+28.75%) |
May 29, 2026 21w ago | S-1/A | $0.0720 $0.0570 | ▲ +20.83% | ▲ +22.02% | $0.0570 (+20.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers